UNSPSC 51422304: Desonide

This classification denotes a therapeutic glucocorticoid with the molecular formula C24H32O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J280872D1O, chemically known as 16-alpha-hydroxyprednisole-16,17-acetonide but generally known as desonide, which bears US NIH Compound Identifier 12536. European Medicines Agency schedules Desonide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07005MIG.

UNSPSC 51422304 Desonide is a Commodity code that captures pharmaceutical products, though the recent state and local procurement activity tagged under this code does not reflect desonide (a topical corticosteroid) but rather naloxone and drug deactivation systems. Seminole County, Florida's IFB60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023, solicits 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding for community health initiatives. The procurement requires quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with all shipping and delivery costs included in vendor proposals. Bidders must submit electronically through the county's e-Procurement Portal, provide unit costs for each line item, comply with drug-free workplace certification and E-Verify requirements, maintain workers' compensation and commercial general liability insurance, and accept a three-month probationary period during which the county may terminate with or without cause. The contract runs for an initial two years with an option for one-year renewal, potentially funded through FEMA, which subjects contractors to federal environmental compliance and audit requirements.

The mismatch between the code's nominal scope (desonide, a prescription steroid) and the actual procurement (naloxone and harm-reduction equipment) suggests this code sees limited relevant recent activity for desonide-specific products in state and local procurement. The single tracked opportunity reflects a Florida county's opioid-response spending rather than dermatological pharmaceutical procurement. Business development professionals evaluating opportunities under this Commodity code should verify whether target agencies are actually procuring desonide formulations or whether related pharmaceutical and public-health categories may better capture active state and local demand.